P-1 "McCrea, Deborah" < m ccrea@ taftlaw .com > 10/28/2009 02:00 PM To NCIC OPPT@EPA cc "Bilott, Robert A." < bilott@taftlaw.com> bcc Subject 10/28/2009 Letter To EPA Docket Center A t 3i3-6- ) Taft/ /Deborah McCrea Legal Assistant Taft Stettinius & Hollister LLP 425 Walnut Street, Suite 1800 Cincinnati, Ohio 45202-3957 /Tel: 513.381.2838* Fax: 513.381.0205 www.taftlaw.com mccrea@taftlaw.com ^3 \JD O so 1 ;o r'Tn.r*'* sr cx> Internal Revenue Service Circular 230 Disclosure: As provided for in Treasury regulations, advice (if any) relating to federal taxes that is contained in this communication (including attachments) is not intended or written to be used, and cannot be used, for the purpose of (1) avoiding penalties under the Internal Revenue Code or (2) promoting, marketing or recommending to another party any transaction or matter addressed herein.

Reed, PhD Staff Vice President Environmental Technology and Safety Services BEST COPY AVAILABLE 89050000598 0 s0000 5 98 I 3M ENVIRONMENTAL LABORATORY PRO JEC T NO.E05-0120 NO TSCA CBI Analytical Report Revised August 12, 2005 Initial Quantitative Screening of Commercial Lots of Human Serum Obtained in 2004 for Endogenous Fluorochemicals Using Protein Precipitation and Liquid Chromatography/Tandem Mass Spectrometry Laboratory Request Number E05-0120 Testing Laboratory 3M Environmental Health and Safety Operations 3M Environmental Laboratory 3M Environmental Laboratory Project Lead Mark E .

`The mechanisms and pathways leading to the presence of PFOS in human blood are not well characterized but likely involve environmental exposure to PFOS or its precursor molecules and residual levels of POS or POS precursors in industrial and commercial o 600006 MPageetn36 `products.

p' 3M /\-(tHP.6~ $S~7 3M ENVIRONMENTAL LABORATORY PROJECT NO.EOS-0442 Analytical Report Definitive Study: Quantitative Screening of Commercial Lots of Human Serum Obtained in 2004 for Endogenous Fluorochemicals Using Solid Phase Extraction and Liquid Chromatography/Tandem Mass Spectrometry Laboratory Request Number: E05-0442 Testing Laboratory 3M Environmental Health and Safety Operations 3M Environmental Laboratory 3M Environmental Laboratory Project Lead Mark E.

British Journal of Cancer (2005) 92, 580-586 2005 Cancer Research UK All rights reserved 0007 - 0920/05 $30.00 www.bjcancer.com Cancer mortality in a cohort of asbestos textile workers E Pira1, C Pelucchi*'2, L Buffoni1, A Palmas1, M Turbiglio1, E Negri2, PG Piolatto1 and C La Vecchia2,3 1 Dipartimento di Traumatologia, Ortopedia e Medicine del Lavoro, Universita degli Studi di Torino, via Zuretti 29, 10126 Torino, Italy; 2Istituto di Ricerche Farmacologiche 'Mario Negri', via Eritrea 62, 20157 Milano, Italy; 3Istituto di Statistica Medica e Biometria, Universita degli Studi di Milano, via Venezian 1, 20133 Milano, Italy A cohort of 889 men and 1077 women employed for at least 1 month between 1946 and 1984 by a former Italian leading asbestos (mainly textile) company, characterised by extremely heavy exposures often for short durations, was followed up to 1996, for a total of 53 024 person-years of observation.

XXXX, XXX, XXX-XXX US00007259 Environmental Science & Technology Letters____________ production of these compounds have been offset by increases in developing regions such as Asia.8 Limited available data suggest widespread exposure to replacement (short-chain) PFASs may also adversely affect human health.11,12 Fluman PFAS exposure includes dietary sources, household dust, air, and drinking water.13'14 Exposure from drinking water is a serious concern because of the high aqueous solubility of many PFASs.13'16 Relatively low PFAS concentrations can lead to elevated exposures in the general population.17 Elevated PFAS concentrations in U.S. drinking water have been reported in numerous regions/3'16'18'19 especially near industrial sites that produce or use them.6'16'20 For example, perfluorooctanoic acid (PFOA) concentrations 190-fold higher than the lifetime health advisory (70 n g/L ) recommended by the U.S.

PAGE 1 MATERIAL SAFETY DATA SHEET CIBA-GEIGY CORPORATION ADDITIVES DIVISION SEVEN SKYLINE DRIVE HAWTHORNE, NEW YORK 10532 (91A) 785-2000 EMERGENCY PHONE NUMBER< (800) 888-8372 SECTION I-IDENTITY INFORMATION IDENTITY (TRADENAME).

-c$e*h c Ei C n a Rl E 5 * " PETE" L 01 *a CU2 LAWRENCEP HALR * SIMM Oh 5 cSr<C OOuGlAS JjfAgfT E5WAH$i ll.. w C"*C_r hCRhCnC NOB* S SOLOMON B'STihE a MCAfiNC* Llv $ rujiMT-o ,OK rox EVENS OEREKa IlOOh SanDRa j b OCnnh kEnnETh a qriGG ji Obk and wihoinia Only Law offices Keller and Heckman 1150 17TM STREET.

The diagnosis of tuberculosis and of silicosis was further discussed at subsequent meetings at which the leading paper was presented by Drs.

3Afl A&2S16- $S7Z 3M ENVIRONMENTAL LABORATORY PROJECT NO.E05-0442 Analytical Report Definitive Study: Quantitative Screening of Commercial Lots of Human Serum Obtained in 2004 for Endogenous Fluorochemicals Using Solid Phase Extraction and Liquid Chromatography/Tandem Mass Spectrometry Laboratory Request Num ber EQ5-0442 Testing Laboratory 3M Environmental Health and Safety Operations 3M Environmental Laboratory' _________________ _ _ _____________________________________________ ;_________ _ 3M Environmental Laboratory Project Lead Mark E.

Both 9 000112 exposure to, and metabolic production of target analytes will lead to artificially long halflife estimations.

FILE NAME Kubota KUB DATE 2008 DOC KUB038 DOCUMENT DESCRIPTION Legal - Form Interrogatories - General ATTORNEY OR PARTY WITHOUT ATTORNEY Name State Bar number and address DISC JEJF REY EFFREY A.

o 3M EtWIRONMENTAL LABORATORY PROJECT NO.E05-O442 Analytical Report Definitive Study: Quantitative Screening of Commercial Lots of Human Serum Obtained in 2004 for Endogenous Fluorochemicals Using Solid Phase Extraction and Liquid Chromatography/Tandem Mass Spectrometry Laboratory Request Num ber E05-0442 Testing Laboratory 3M Environmental Health and Safety Operations 3M Environmental Laboratory 3M Environmental Laboratory Project Lead Mark E.

These characteristics, along with the fact that many HDAC inhibitors synergistically enhance cell death to DNA damaging agents, have pushed them forward as lead cancer treatment compounds with many entering, or currently undergoing, clinical trials (Minucci and Pelicci 2006).

pISSN : 2093-7911 eISSN : 2093-7997 Safety and Health at Work 2010;1:51-60 Original Article Characteristics of Occupational Exposure to Benzene during Turnaround in the Petrochemical Industries Eun-Kyo CHUNG1, Jung-Ah SHIN1, Byung-Kyu LEE1, Jiwoon KWON1, Naroo LEE1, Kwang-Jae CHUNG1, Jong-Han LEE1, In-Seop LEE1, Seong-Kyu KANG1 and Jae-Kil JANG2 1Department of Occupational Environment Research, Occupational Safety and Health Research Institute, 2Occupational Safety and Health Training Institute, KOSHA, Incheon, Korea Objectives: The level of benzene exposure in the petrochemical industry during regular operation has been well established, but not in turnaround (TA), where high exposure may occur.